Create Standing Committee on Health

Summary#

• This resolution would create a new, permanent Committee on Health in the U.S. House of Representatives.

• Its goal is to group key health topics under one committee, including oversight of major health agencies.

• Key changes:

  • Creates a standing Committee on Health focused on:
    • Biomedical research and development, including the Food and Drug Administration (FDA).
    • Public health and quarantine, including the Centers for Disease Control and Prevention (CDC).
    • Health, health facilities, and health care paid for with general tax dollars (not veterans’ health care).
  • Moves some health-related duties away from the Energy and Commerce Committee to the new Health Committee.
  • Limits the Education and the Workforce Committee’s role by excluding “health insurance programs” from its general scope.
  • Veterans’ health care remains under the Veterans’ Affairs Committee.

What it means for you#

• General public

  • No direct change to your health coverage or care. This is an internal House change about who handles health bills and hearings.
  • Future health legislation and oversight of agencies like FDA and CDC would run through a dedicated Health Committee.

• Patients and families

  • Oversight of FDA drug and device safety and CDC public health work would be handled by the new committee.
  • This could shape how quickly Congress reviews health crises, approvals, and safety issues.

• Workers and employers

  • Oversight of employer health insurance rules (like job-based plans) would shift away from the Education and the Workforce Committee.
  • Future changes to health insurance rules may be written and debated in the new Health Committee.

• Health providers and health systems

  • A single committee would lead on many federal health programs funded by general revenues, which could change how congressional oversight is organized.
  • Veterans’ health programs are not affected.

• Drug, device, and biotech companies

  • Congressional oversight of FDA policies would move to the Health Committee, which may affect how industry engages with lawmakers.

• State and local governments

  • A dedicated panel would oversee CDC and public health matters, which may change who states work with in Congress during health emergencies.

Expenses#

• No publicly available information.

Proponents' View#

• Puts health policy under one roof, making oversight of FDA, CDC, and public health more focused and effective.
• Reduces turf battles between committees, which can slow action on health crises and major reforms.
• Elevates health as a national priority with a committee dedicated to it.
• Clarifies who handles employer health insurance issues in the House.
• Could speed up hearings and updates to health laws by concentrating expertise.

Opponents' View#

• Breaks up long-standing expertise in existing committees, especially Energy and Commerce, which already handles much of health policy.
• May create new confusion and disputes over what counts as “health” or “general revenues,” slowing bills instead of speeding them up.
• Risks overlap with other committees (like Ways and Means on Medicare/Medicaid) and could complicate complex programs.
• Adds administrative costs and staffing needs for a new committee without clear proof of better results.
• Could narrow perspectives by separating health from related areas (like commerce or labor), reducing integrated policymaking.